A comprehensive review highlights quercetin, a naturally occurring flavonoid, as a potent multi-target agent against diverse cancers through apoptosis induction, angiogenesis suppression, and chemosensitization. Found abundantly in traditional herbs and common foods, this compound demonstrates synergistic potential in adjuvant cancer therapy while offering protective benefits against treatment side effects.

Quercetin emerges as a scientifically supported "guardian" for lung health, offering protection against key environmental and pathological threats like pollution, inflammation, and viruses. While further clinical research is ongoing, current evidence supports its consideration within a comprehensive strategy for maintaining respiratory and systemic well-being. Selecting a high-quality, adequately dosed, multi-component supplement is paramount for realizing its potential benefits. As environmental challenges persist, quercetin presents a promising natural approach to bolstering pulmonary resilience.

Quercetin, a naturally occurring flavonoid abundant in colorful fruits, vegetables, and beverages, demonstrates significant multi-system health benefits according to scientific research. This bioactive compound, once considered a "Vitamin P," is now recognized for its antioxidant, anti-inflammatory, and immune-modulating properties.

Scientific evidence continues to validate the extensive theRapeutic properties ofallicin (diallyl thiosulfinate), the primary bioactive compound derived from garlic (Allium sativum*). This organic sulfur molecule, formed enzymatically when raw garlic is crushed or chopped, demonstrates significant potential as a complementary approach to modern health challenges.

Menopause (ages 45-55) marks a universal tRansition for women, yet remains critically under-addressed. In China alone, 120 million women currently experience menopause – a figure projected to exceed 210 million nationwide (1/6 of the population) by 2030 per WHO data. Globally, menopausal women will surpass 1.2 billion this decade.

Cognitive dysfunction, including Alzheimer’s disease and vascular dementia, affects millions worldwide. By 2050, AD cases alone are projected to reach 45 million, making it the fourth-leading cause of death among the elderly. In China, AD prevalence in adults aged 60–89 has risen sharply, underscoring the urgent need for effective treatments. While current theRapies address symptoms of secondary dementia (e.g., stroke- or diabetes-related), no drugs effectively halt or reverse primary neurodegenerative conditions like AD.

Fisetin, a flavonoid first identified in the smoke tree (Rhus cotinus) in the 19th century, is gaining attention for its promising role in treating pulmonary fibrosis—a deadly lung disease with limited therapeutic options. Historically studied for its antioxidant properties, Fisetin’s anti-inflammatory and senolytic (senescent cell-clearing) effects are now in focus, particularly its ability to combat fibrosis by targeting cellular aging pathways